Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review

BACKGROUND: The use of vasoactive agents like arginine vasopressin (AVP) and terlipressin to treat hypotension or persistent pulmonary hypertension in critically ill preterm neonates is increasing. Therefore, a systematic review of the available data on dosing, efficacy and safety of AVP and terlipr...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsaadi, Abdulrahman Salim, Sushko, Katelyn, Bui, Vivian, Van Den Anker, John, Razak, Abdul, Samiee-Zafarghandy, Samira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191613/
https://www.ncbi.nlm.nih.gov/pubmed/34179513
http://dx.doi.org/10.1136/bmjpo-2021-001067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191613/
https://www.ncbi.nlm.nih.gov/pubmed/34179513
http://dx.doi.org/10.1136/bmjpo-2021-001067

Ejemplares similares